Stay updated on INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial

Sign up to get notified when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added 'Gastrointestinal stromal tumor' as a disease term and a Resources section linking Genetic and Rare Diseases Information Center to the page.
    Difference
    0.1%
    Check dated 2026-04-02T15:47:49.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T06:35:23.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. The previous revision is no longer active.
    Difference
    0.0%
    Check dated 2026-03-12T01:46:03.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Updated metadata shows a new revision label (v3.4.2) and added dates (2026-02-05, 2026-12, 2026-01-16, 2026-01). Older notices including the government funding lapse message and the previous revision (v3.4.1) were removed.
    Difference
    0.3%
    Check dated 2026-02-11T12:26:34.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added a site-wide funding/status notice indicating government funding impacts and updated the page revision from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T06:46:46.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    A glossary toggle was added and several metadata/versioning fields were updated or renamed (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), with the previous QC wording and No FEAR Act data removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T04:46:32.000Z thumbnail image

Stay in the know with updates to INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.